Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Relative risk reduction: Misinformative measure in clinical trials and COVID-19 vaccine efficacy

Published:2022-12 Issue: Volume:1 Page:100074
ISSN:2772-6533
Container-title:Dialogues in Health
language:en
Short-container-title:Dialogues in Health

Author:

Brown Ronald B.

Funder

University of Waterloo

Publisher

Elsevier BV

Reference48 articles.

1. A review of vaccine efficacy measures;Dasgupta;Vaccin Res Open J,2019

2. Outcome reporting bias in COVID-19 mRNA vaccine clinical trials;Brown;Medicina.,2021

3. Communicating risks and benefits: An evidence-based user’s guide;Fischhoff,2011

4. The number needed to treat: a clinically useful measure of treatment effect;Cook;Bmj.,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the benefit-risk balance of drugs. Some lessons from the COVID pandemic;Expert Opinion on Drug Safety;2024-06-19

2. Excess mortality across countries in the Western World since the COVID-19 pandemic: ‘Our World in Data’ estimates of January 2020 to December 2022;BMJ Public Health;2024-05

3. Polypharmacy and Medication Outcome Reporting Bias in Older Patients with COVID-19;BioMed;2023-06-27

4. Absolute Risk Reductions in COVID-19 Antiviral Medication Clinical Trials;Pharmacoepidemiology;2023-03-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP